Literature DB >> 8892611

A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.

V Kronin1, K Winkel, G Süss, A Kelso, W Heath, J Kirberg, H von Boehmer, K Shortman.   

Abstract

Previous work indicated that a subclass of mouse spleen dendritic cells (DC), those bearing CD8alpha, expresses the Fas ligand and restricts peripheral CD4 T cell responses by initiating Fas-mediated apoptosis. To determine whether a similar regulation applies to CD8 T cells, they were purified from normal or from TCR-transgenic mice, and then cultured with purified splenic CD8+ DC or CD8- DC presenting either alloantigens or the specific Ag for the TCR transgene. In all systems studied, the proliferative response of CD8 T cells was markedly less on stimulation with CD8+ DC compared with conventional CD8- DC. However, the basis of this restricted proliferation in response to CD8+ DC was totally different for CD8 T cells than for CD4 T cells. The reduced proliferation of CD8 T cells occurred later in the response than with CD4 T cells. In contrast with CD4 T cells, the reduced proliferation of CD8 T cells occurred even with T cells from Fas-deficient Ipr mice, or with DC from Fas ligand-deficient gld mice, indicating that Fas-induced apoptosis was not involved. Also, in contrast with CD4 T cells, the reduced proliferation of CD8 T cells was completely reversed by the addition of exogenous IL-2. Furthermore, cultures of CD8 T cells with CD8+ DC were found to be deficient in IL-2 production. Accordingly, although CD8+ DC are very efficient at stimulating CD8 T cells into cell division, they are deficient at stimulating endogenous cytokine production. The implications of these different DC regulatory systems are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892611

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Mature T cell seeks antigen for meaningful relationship in lymph node.

Authors:  S P Manickasingham; C Reis e Sousa
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties.

Authors:  Janine Bilsborough; Thaddeus C George; Anne Norment; Joanne L Viney
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

Authors:  V Bronte; D B Chappell; E Apolloni; A Cabrelle; M Wang; P Hwu; N P Restifo
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

4.  Liver tolerance mediated by antigen presenting cells: fact or fiction?

Authors:  A H Lau; A de Creus; L Lu; A W Thomson
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 5.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

Review 6.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Dendritic cell control of tolerogenic responses.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 8.  Dendritic cell modulation as a new interventional approach for the treatment of asthma.

Authors:  Vincent Lombardi; Omid Akbari
Journal:  Drug News Perspect       Date:  2009-10

9.  Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner.

Authors:  Tomomi Toubai; Chelsea Malter; Isao Tawara; Chen Liu; Evelyn Nieves; Kathleen P Lowler; Yaping Sun; Pavan Reddy
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

10.  CD8alpha dendritic cells and immune protection from experimental allergic encephalomyelitis.

Authors:  A Pettersson; X-C Wu; C Ciumas; H Lian; V Chirsky; Y-M Huang; B Bjelke; H Link; B-G Xiao
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.